Investigation of subgroups in confirmatory clinical trials - Scientific guideline | European Medicines Agency (EMA)

Investigation of subgroups in confirmatory clinical trials - Scientific guideline

HumanScientific guidelines

This document provides guidance for assessors in European regulatory agencies on assessment of subgroup analyses in confirmatory clinical trials. It should also be useful to clinical trial sponsors and to assessors engaged in providing scientific advice.

Keywords: Subgroup analysis, confirmatory clinical trials, randomised controlled trials, internal consistency, heterogeneity, biostatistics, assessment of clinical trials, analysis plan, exploratory analysis, benefit/risk assessment

Current version

Document history

Share this page